CClinicalTrials.gg
CompletedNCT04204317FLUOBUpdated Apr 2, 2020

Does Parathyroid Autofluorescence Reduces Unintensional Parathyroidectomy During Total Thyroidectomy?

An observational study in Thyroidectomy, sponsored by Aristotle University Of Thessaloniki. Completed at 1 site in Greece. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-04-02.

Sponsored by Aristotle University Of Thessaloniki · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
180
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the study is to evaluate the effectiveness of autofluorescence in the intraoperative preservation of parathyroids during total thyroidectomy

Read the detailed description

Real-time intraoperative identification and functional maintenance of structures are of major importance in endocrine surgery, with a critical role in clinical outcomes and patients' quality of life. Despite the advances in preoperative imaging techniques, there is still need for precise intraoperative visualizing. Limitations of naked eye inspection and subjectivity of palpation are imposing challenges even for the most experienced surgeons. Nowadays, attention is attracted to intraoperative imaging techniques using Near Infrared Fluorescence (NIRF) with endogenous or exogenous contrast agents. These imaging techniques are attractive in biomedicine due to its high penetration depth and low scattering in human tissue.

Autofluorescence is the ability of several natural substances or drugs to be fluorescent after the absorbance of light or radiation. It has been already proved that parathyroid glands emit their own light after near-infrared (NIR) around 820nm , providing high contrast to the surrounding tissues. This made near-infrared autofluorescence a potential useful tool in hands of experienced endocrine surgeons in order to distinguish parathyroid glands from other anatomic structures during thyroidectomies.

Approximately 7.6% of thyroid surgeries resulted in hypoparathyroidism, with 75% of these cases being transient and 25% being chronic. The mechanisms that underlie hypoPTH are related to disruption of parathyroid arterial supply or venous drainage, mechanical injury, thermal or electrical injury, and either intentional or inadvertent partial or complete removal.

The aim of the present study is to evaluate the value of intra-operative autofluorescence imaging concerning the unintentional excision rate of parathyroids during total thyroidectomy. Moreover, the investigators are going to evaluate correlation of autofluorescence with 24 hours post-operative PTH.

02

Conditions studied

  • Thyroidectomy

Keywords

  • autofluorescence
  • parathyroid glands
  • thyroidectomy
  • FLUOBEAM XS
03

In context

Lead sponsor

Aristotle University Of Thessaloniki is the lead sponsor of 274 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Our sample size of 180 patients has been calculated after power analysis regarding other similar studies with an a=0.05 and Power=0.95.

Inclusion criteria

  • Patient is over 18 years old
  • Patient scheduled for a non-emergency operation
  • Patient eligible for total thyroidectomy

Exclusion criteria

Exclusion Criteria:

  • Patient is participating in another clinical trial which may affect this study's outcomes
  • Prior operation in the neck
  • Primary or secondary hyperparathyroidism
  • Vitamin D deficiency
  • Use of drugs that influences calcium metabolism (Vitamin D analogues, oral calcium supplements, bisphosphonates, teriparatide, thiazide diuretics, aromatase inhibitors)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
180 participants (actual)
Patient registry
No

Groups and cohorts

  • Autofluorescence

    The surgeon will perform the preplanned operation with FLUOBEAM XS. The following intraoperative variables will be recorded for all patients: 1. Surgery date 2. Duration of surgery 3. Operation performed 4. Procedure related comments 5. Number and location of the visualized glands 6. Intra-operative autofluorescence score (either 0 (no visualization or 1 visualization) for each gland

  • Control

    The surgeon will perform the preplanned operation without FLUOBEAM XS. The following intraoperative variables will be recorded for all patients: 1. Surgery date 2. Duration of surgery 3. Operation performed 4. Procedure related comments

06

What researchers measure

Primary outcomes

  1. The contribution of intra-operative autofluorescence imaging on unintentional excision rate of parathyroids during total thyroidectomy.

    The aim of the study is to evaluate the use of autofluorescence to distinguish parathyroid glands during thyroidectomy

    Time frame: 6 months

Secondary outcomes

  1. Detecting the changes of practice in performing total thyroidectomy when monitoring parathyroids with autofluorescence.

    If autofluorescence is proved to be a useful tool in endocrine surgeons hands, the preservation of parathyroid glands during thyroidectomy would be easier.

    Time frame: 6 months

  2. Comparing autofluorescence monitored minimal invasive total thyroidectomy with classic minimal invasive total thyroidectomy

    To compare the duration and safety of minimal invasive thyroidectomy with or without FLUOBEAM XS

    Time frame: 6 months

  3. Correlating autofluorescence with 24 hours post-operative PTH.

    This study aims to analyze statistically and prove the possible correlation of autofluorescence results with post-operative PTH

    Time frame: 7 months

  4. Identifying the cut-off points that predict low PTH levels (less than 20pg/ml)

    After statistical analysis, we will try to find the cut-off point of PTH levels after autofluorescence results (if they are statistical significant correlated with post-operative PTH)

    Time frame: 7 months

  5. Identifying and analyzing problematic groups of patients

    This study will sign out the disadvantages of FLUOBEAM XS or cases that its use should be avoided.

    Time frame: 6 months

07

Study locations

1 site
  • AHEPA University Hospital of Thessaloniki
    Thessaloniki, 54636, Greece
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04204317
Lead sponsor
Aristotle University Of Thessaloniki
Responsible party
Papavramidis Theodossis (Assistant Professor of Surgery, Aristotle University Of Thessaloniki) — Principal investigator
First posted
Dec 18, 2019
Start date
Dec 17, 2019
Primary completion
Mar 27, 2020
Completion
Mar 27, 2020
Last update
Apr 2, 2020

Study contacts

Theodossis S Papavramidis, MD, PhD
principal investigator · AHEPA University Hospital of Thessaloniki, Greece

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion